ModeX Therapeutics

About ModeX Therapeutics

ModeX Therapeutics is a biotechnology company focused on uniting the power of multiple medicines in a single molecule to combat complex diseases. Their mission is to advance technologies that shift the paradigm in drug development through modular platforms and multispecific biologics.

Products & Services

MSTAR Platform:A modular platform designed to combine multiple biologics into single molecules for treating complex diseases.

Nanoparticle Vaccine Platform:A platform focused on developing nanoparticle-based vaccines.

Multispecifics:Therapies that integrate multiple biologics into a single molecule to address multifaceted diseases.

Specialties

Multispecific Biologics Drug Development Nanoparticle Vaccines Biomedical Imaging Immunology Virology Oncology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Contract T: - FT: Contract	A: 168000000 MR: - FA: up to $168 million FAN: 168000000	D: 2023-12-26 FD: 2023-12-26	1 investors

Contract Latest

2023-12-26

$168.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Giovanni Abbadessa

Chief Medical Officer

J

John Mascola

Chief Scientific Officer

LinkedIn (Pro only)

J

Ji Zhang

Chief Operating Officer

LinkedIn (Pro only)

V

Vijay Chhajlani

Chief Technology Officer

G

Gary Nabel

Co-Founder, President and CEO, ModeX Therapeutics

E

Elias Zerhouni

Co-Founder and Chairman of ModeX Therapeutics, President and Vice Chairman of OPKO Health

View 29 more team members with Pro

Unlock Full Team Directory

Recent News